Filter

61 - 70 of 148 Results

  • The Kaiser Family Foundation/Washington Post Climate Change Survey

    Report

    Our latest partnership survey with The Washington Post examines the public’s views, awareness, and preferences related to climate change. The poll assesses the public’s belief in whether human activity is causing climate change and global warming, as well as levels of concern and support for policy solutions. A companion survey of U.S. teens explores how this age group views the issue of climate change and its potential impact on their generation.

  • KFF COVID-19 Vaccine Monitor: December 2020

    Report

    This initial survey for the KFF COVID-19 Vaccine Monitor tracks the public’s attitudes and experiences with COVID-19 vaccinations, with a focus on sub-groups of Americans. It explores confidence in vaccines, assesses trust in messengers, and highlights key challenges for vaccination efforts.

  • Who Might Lose Eligibility for Affordable Care Act Marketplace Subsidies if Enhanced Tax Credits Are Not Extended?

    Policy Watch

    This analysis looks at the individual market enrollees who make at least four times the federal poverty level who would no longer be eligible for any tax credits if the current ACA Marketplace enhanced subsidies expire at the end of this year. Compared to other people with similar incomes, these enrollees are more likely to be early retirees, self-employed and living in rural areas.

  • Key Data on Health and Health Coverage in South Carolina

    Fact Sheet

    This fact sheet draws on data from “Health and Health Coverage in the South: A Data Update” to highlight findings for South Carolina. The findings show the current status of health and health coverage in the state and the potential coverage gains that may be achieved through the Affordable Care Act.

  • Policy Considerations as Children Ages 5-11 Become Eligible for the COVID-19 Vaccine

    News Release

    A new KFF issue brief lays out key factors for the successful rollout of COVID-19 vaccinations for younger children, ages 5 to 11. This week, the Food and Drug Administration’s (FDA) advisory committee will meet to vote on a request to authorize the Pfizer vaccine for younger children. A final FDA decision, and Centers for Disease Control and Prevention actions, will follow as soon as the first week in November. As the Biden administration plans…

  • Vaccine Hesitancy in Rural America

    Poll Finding

    Based on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among rural Americans toward the coronavirus and willingness to get a potential vaccine.